Meridian Bioscience Sets a New Sustainability Standard in Diagnostic Assay Development with the Launch of Two New Animal-Free Immunoassay Interference Blockers

The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of two new immunoassay interference blockers, K-Block™, and Mouse-Free IgG.

Buprenorphine, autism diagnoses, and long Covid: the most-read First Opinion essays of 2023

In a year of abortion restrictions, biotech industry upheaval, and revolutionary drug approvals, First Opinion strived to publish the most surprising, provocative, and conversation-starting essays

December 29, 2023

Imported case of monkeypox leads to local transmission in China

Monkeypox (mpox) is a zoonotic disease caused by the mpox virus (MPXV) that has been primarily limited to Central and West African nations since its

September 15, 2023

Investigating dosage in hyperbaric oxygen therapy for post-covid conditions

Hyperbaric oxygen therapy, giving patients 100 percent oxygen at a pressure corresponding to 10-20 meters below sea level, has been around for almost 100 years.

February 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.